razormd

Antigenics, Dendreon and Cell Genesys Find Hope in Overseas Treatment Approvals

Utter nonsense!...getting drug approval in Russia and many other companies is nothing more than a matter of seeing that the appropriate amount of silver crosses the right palms...they could care less the ultimate consequences...and although the FDA is strict, they NO doubt SAVE many more times the number of lives with their protocols than lose lives due to a POTENTIALLY beneficial therapeutic not making it through the sieve!...and were they not so strict we would be overrun by every kind of charlatan drug pusher and quack device scam imaginable at a financial cost to consumers of who knows how many billions.

Nine Stem Cell Stocks to Add to Your Portfolio

You might also want to look at a small company with the symbol OPXA...they have some interesting stem cell work and their lead product -- not stem cell related -- is in phase IIb...see:

www.opexatherapeutics....